Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05396_nanopub.RAEsTE7_6dngvcdYUTY6cH8iLw8F6AS0Xw9P0TKC_8pQ4#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05396 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05396 label "albumin-interferon alpha [drugbank:DB05396]" assertion.
- drugbank:DB05396 seeAlso DB05396 assertion.
- drugbank:DB05396 description "Albumin-interferon alpha (Albuferon) is a novel, long-acting form of interferon alpha. Recombinant interferon alpha is approved for the treatment of hepatitis C, hepatitis B, and a broad range of cancers. Human Genome Sciences modified interferon alpha to improve its pharmacological properties by using the company's proprietary albumin fusion technology. Human Genome Sciences is developing Albuferon as a potential treatment for chronic hepatitis C." assertion.
- drugbank:DB05396 identifier "drugbank:DB05396" assertion.
- drugbank:DB05396 title "albumin-interferon alpha" assertion.
- drugbank:DB05396 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05396 drugbank_vocabulary:drugbank-id "DB05396" assertion.
- drugbank:DB05396 bio2rdf_vocabulary:x-identifiers.org DB05396 assertion.
- drugbank:DB05396 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05396" assertion.
- drugbank:DB05396 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05396 bio2rdf_vocabulary:identifier "DB05396" assertion.